-
Comment Letter
UDCA treatment against COVID-19: Do we have enough clinical evidence for drug repurposing?
- Luisa Ojeda-Fernández, Marta Baviera, Giulia Macaluso, Simone Schena, Mauro Tettamanti, Massimo Cartabia, Andreana Foresta, Pier Manuccio Manucci, Alessandro Nobili, Giuseppe Remuzzi, and Carla Roncaglioni.
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
- J. Intern. Med. 2024 Jan 1; 295 (1): 110112110-112.
no abstract available
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.